Fundraising FoxMountain Group Capital — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests.
AI & Machine LearningBiotechDigital HealthMedical DevicesAlbuquerque, US
Alexander Hafez(Executive Officer, Director, Promoter)inNikolaos Mellios(Director, Promoter)
Co-investorsCottonwood Technology FundTramway Venture Partners
In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.
BiotechConsumerFoodTechHealthtechNashville, US
Randolph Legg(Chief Executive Officer)inScott Holmstrom, Ph.D.(Chief Scientific Officer)Eric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)Diane Hirakawa(Director)
Co-investorsBioBrit
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
MiNDERA Corporation
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.